ULTRASOUND EVAL OF FLOW RELATED ARTERIAL DILATION IN HIV INFECTED CHILDREN
HIV 感染儿童血流相关动脉扩张的超声评估
基本信息
- 批准号:7379489
- 负责人:
- 金额:$ 0.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-12-01 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Ultrasound study of brachial artery flow-mediated dilation is emerging as a commonly used test for investigation of endothelial function, specifically risk for coronary artery disease. In children, femoral artery flow mediated dilation has been used to identify abnormalities in children with familial dyslipidemia and brachial artery flow in children with Kawasaki Syndrome. We hypothesize femoral and/or brachial artery flow mediated dilation may be useful in identifying abnormalities in flow mediated dilation in HIV infected children and may correlate with the observed abnormalities in cholesterol and triglycerides now commonly observed in HIV infected children treated with protease inhibitors. The vascular endothelium plays a central role in the regulation of vascular homeostasis by releasing paracrine factors that influence vascular tone, blood fluidity, and inflammation. A prototypical and relevant endothelial product is nitric oxide (NO), which is a vasodilator and an inhibitor of platelet activity, leukocyte adhesion, and smooth muscle cell proliferation. NO is synthesized from the amino acid L-arginine by the enzyme nitric oxide synthase (eNOS), which established that endothelium-dependent flow-mediated dilation (FMD) is dependent on nitric oxide production and that this response can be detected in the brachial or femoral artery using the non-invasive methodology proposed for the present study. Loss of the biologic activity of endothelium-derived NO is important in both the early and later stages of atherosclerosis. The clinical relevance of endothelial dysfunction has been established in adults by demonstrating a link between endothelial dysfunction and cardiac events. In children, high resolution ultrasound of the femoral or brachial artery has been used to measure changes in arterial diameter in response to reactive hyperemia and to glycertrinitrite. Flow increase is induced by deflation of a blood pressure cuff placed around the thigh distal to the femoral artery or deflation of a blood pressure cuff placed around the upper arm. The cuff is released after 3-5 minutes and the artery scanned continuously from 30 seconds before to 90 seconds after deflations. Ten minutes later, a second resting scan is recorded. Changes in diameter of 0.1-0.2 mm can be detected accurately (Sorensen KE, et al. Impairment of endothelial-dependent dilatation is an early even in children with Familial Hypercholesterolemia and is related to the lipoprotein 9a) (Level. J. Clin. Invest. 1994;93:50-55).
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。肱动脉血流介导的扩张的超声研究正在成为研究血管内皮功能,特别是冠状动脉疾病风险的一种常用测试方法。在儿童中,股动脉血流介导的扩张已被用于识别家族性血脂异常儿童和川崎综合征儿童的臂动脉血流异常。我们推测股动脉和/或肱动脉血流介导的扩张可能有助于识别HIV感染儿童血流介导的扩张异常,并可能与目前观察到的在接受蛋白酶抑制剂治疗的HIV感染儿童中观察到的胆固醇和甘油三酯异常相关。血管内皮细胞通过释放影响血管张力、血液流动性和炎症的旁分泌因子,在调节血管动态平衡中发挥核心作用。一氧化氮(NO)是一种典型的和相关的内皮产物,它是一种血管扩张剂,也是血小板活性、白细胞黏附和平滑肌细胞增殖的抑制因子。NO是由一氧化氮合酶(ENOS)催化氨基酸L-精氨酸合成的,eNOS确立了内皮依赖的血流介导的扩张依赖于一氧化氮的产生,并且这种反应可以在本研究中提出的无创性方法中检测到。内皮来源的NO生物活性的丧失在动脉粥样硬化的早期和晚期都是重要的。通过证明内皮功能障碍与心脏事件之间的联系,已经在成人中确立了内皮功能障碍的临床相关性。在儿童中,股动脉或臂动脉的高分辨率超声被用来测量对反应性充血和甘油三硝酸盐反应的动脉直径的变化。血流增加是由股动脉远端大腿周围的血压袖带放气或上臂周围的血压袖带放气引起的。3-5分钟后松开袖带,从放气前30秒到放气后90秒连续扫描动脉。10分钟后,记录第二次休眠扫描。可以准确地检测到0.1-0.2 mm的直径变化(Sorensen Ke,et al.即使在家族性高胆固醇血症的儿童中,内皮依赖性扩张的损害也是早期的,并且与脂蛋白9a)(水平)有关。J·克莱恩。投资。1994年;93:50-55)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen I. Pelton其他文献
in children: the contribution of clonal expansion and serotype switching.
在儿童中:克隆扩增和血清型转换的贡献。
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
W. Hanage;C. Bishop;Susan S. Huang;Abbie;E. Stevenson;Stephen I. Pelton;M. Lipsitch;A. Jonathan;Finkelstein - 通讯作者:
Finkelstein
Adolescents at Risk: The Case for Meningococcal Vaccine
- DOI:
10.1016/j.jadohealth.2009.12.013 - 发表时间:
2010-02-01 - 期刊:
- 影响因子:
- 作者:
Martin C. Mahoney;Stephen I. Pelton - 通讯作者:
Stephen I. Pelton
Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of <em>Haemophilus influenzae</em>
- DOI:
10.1016/s0022-3476(80)80182-x - 发表时间:
1980-09-01 - 期刊:
- 影响因子:
- 作者:
Paul A. Shurin;Stephen I. Pelton;Ira B. Tager;Dennis L. Kasper - 通讯作者:
Dennis L. Kasper
The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines
- DOI:
10.1016/j.jadohealth.2016.04.012 - 发表时间:
2016-08-01 - 期刊:
- 影响因子:
- 作者:
Stephen I. Pelton - 通讯作者:
Stephen I. Pelton
The old man’s friend
- DOI:
10.1186/s41479-018-0052-7 - 发表时间:
2018-07-25 - 期刊:
- 影响因子:6.200
- 作者:
Ger T. Rijkers;Stephen I. Pelton - 通讯作者:
Stephen I. Pelton
Stephen I. Pelton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen I. Pelton', 18)}}的其他基金
Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis
预防复发性和慢性化脓性中耳炎的单一抗原策略
- 批准号:
9105737 - 财政年份:2015
- 资助金额:
$ 0.66万 - 项目类别:
RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN
FLUMIST 在 HIV INF 儿童中的安全性和免疫原性的随机试验
- 批准号:
7606258 - 财政年份:2007
- 资助金额:
$ 0.66万 - 项目类别:
LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40)
儿童 HIV 感染的晚期结果(PACTG 219C 第 40 版)
- 批准号:
7606299 - 财政年份:2007
- 资助金额:
$ 0.66万 - 项目类别:
SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN PAPILLOMAVIRUS
四价人乳头病毒的安全性和免疫原性研究
- 批准号:
7606296 - 财政年份:2007
- 资助金额:
$ 0.66万 - 项目类别:
LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40)
儿童 HIV 感染的晚期结果(PACTG 219C 第 40 版)
- 批准号:
7379534 - 财政年份:2005
- 资助金额:
$ 0.66万 - 项目类别:
IMMUNOGENICITY OF LIVE ATTENUATED VARICELLA VACCINE HIV INFECTED CHILDREN
水痘减毒活疫苗对 HIV 感染儿童的免疫原性
- 批准号:
7379533 - 财政年份:2005
- 资助金额:
$ 0.66万 - 项目类别:
RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN
FLUMIST 在 HIV INF 儿童中的安全性和免疫原性的随机试验
- 批准号:
7379515 - 财政年份:2005
- 资助金额:
$ 0.66万 - 项目类别:
ULTRASOUND EVAL OF FLOW RELATED ARTERIAL DILATION IN HIV INFECTED CHILDREN
HIV 感染儿童血流相关动脉扩张的超声评估
- 批准号:
7206287 - 财政年份:2004
- 资助金额:
$ 0.66万 - 项目类别:
LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40)
儿童 HIV 感染的晚期结果(PACTG 219C 第 40 版)
- 批准号:
7206308 - 财政年份:2004
- 资助金额:
$ 0.66万 - 项目类别:
RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN
FLUMIST 在 HIV INF 儿童中的安全性和免疫原性的随机试验
- 批准号:
7206304 - 财政年份:2004
- 资助金额:
$ 0.66万 - 项目类别:
相似海外基金
EVAL-FARMS: Evaluating the Threat of Antimicrobial Resistance in Agricultural Manures and Slurries
EVAL-FARMS:评估农业肥料和泥浆中抗菌素耐药性的威胁
- 批准号:
NE/N019881/1 - 财政年份:2016
- 资助金额:
$ 0.66万 - 项目类别:
Research Grant
EVAL OF IMPCT OF JAPANESE ENCEPHALITIS VACCINE IN CAMBODIA
日本脑炎疫苗在柬埔寨的影响评估
- 批准号:
8751054 - 财政年份:2014
- 资助金额:
$ 0.66万 - 项目类别:
Eval of chem induced micro agglomeration tech to enhance dewatering prfm of flocculated MFT
化学诱导微团聚技术提高絮凝 MFT 脱水效率的评价
- 批准号:
471164-2014 - 财政年份:2014
- 资助金额:
$ 0.66万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Comp C-Eval of Best Urologic Management for Newborns with SB
Comp C-SB 新生儿最佳泌尿外科管理的评估
- 批准号:
8915963 - 财政年份:2014
- 资助金额:
$ 0.66万 - 项目类别:
Comp C-Eval of Best Urologic Management for Newborns with SB
Comp C-SB 新生儿最佳泌尿外科管理的评估
- 批准号:
8819873 - 财政年份:2014
- 资助金额:
$ 0.66万 - 项目类别:
Comp C-Eval of Best Urologic Management for Newborns with SB
Comp C-SB 新生儿最佳泌尿外科管理的评估
- 批准号:
9108702 - 财政年份:2014
- 资助金额:
$ 0.66万 - 项目类别:
Comp C-Eval of Best Urologic Management for Newborns with SB
Comp C-SB 新生儿最佳泌尿外科管理的评估
- 批准号:
9318122 - 财政年份:2014
- 资助金额:
$ 0.66万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program-Tracking and Eval Core
特拉华州临床和转化研究 ACCEL 项目跟踪和评估核心
- 批准号:
10437683 - 财政年份:2013
- 资助金额:
$ 0.66万 - 项目类别:
NORTH CAROLINA WELL INTEGRATED SCREENING AND EVAL FOR WOMEN
北卡罗来纳州针对女性的综合筛查和评估
- 批准号:
8659951 - 财政年份:2013
- 资助金额:
$ 0.66万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program-Tracking and Eval Core
特拉华州临床和转化研究 ACCEL 项目跟踪和评估核心
- 批准号:
10223331 - 财政年份:2013
- 资助金额:
$ 0.66万 - 项目类别:














{{item.name}}会员




